New Acting Director of FDA Chosen

March 13, 2019
The FDA has named an acting commissioner to replace Scott Gottlieb.

The FDA has named an acting commissioner to replace Scott Gottlieb, who announced last week his intention to resign after two years at the agency.

The interim head will be Dr. Norman “Ned” Sharpless, now head of the National Cancer Institute. Sharpless, an oncologist, was known for advocacy for cancer research during his 18 months as institute director.

Gottlieb is leaving within weeks, after two years heading the FDA, to spend more time with his family. He mostly made his mark with actions relating to pharmaceuticals and tobacco, but during his tenure, the FDA did carry forward a couple of food-labeling initiatives, inherited from the Obama administration, on genetically modified food and enhancements to the Nutrition Facts panel.

Sharpless was named as interim FDA head on March 12 by Health and Human Services Secretary Alex Azar at a hearing before a U.S. House subcommittee. The Washington Post reports that he may be considered a candidate for permanent FDA director.

Sponsored Recommendations

Refrigerated transport services you can count on

Ensure product quality from origin to final destination with refrigerated shipping solutions from Schneider.

4 shipping challenges that a dedicated carrier can solve

Navigating the logistics industry is challenging. Find out how a dedicated transportation solution can solve some of the most common shipping challenges.

Dedicated lightweight solution maximizes bottled water payload

A leading bottled water company needed a carrier to transport water from 29 plants to retailers. The challenge? Handling over 46,000 pounds. Read the study.

Recipe for successful growth: Schneider’s dedicated fleet services helps bakery rise

Learn how a large bakery company complimented their private fleet with Schneider Dedicated freight services to increase freight capacity, amplify visibility & reduce costs.